Thematische Bibliographien / New medicines

Inhaltsverzeichnis

  1. Zeitschriftenartikel
  2. Dissertationen
  3. Bücher
  4. Buchteile
  5. Konferenzberichte
  6. Berichte der Organisationen

Auswahl der wissenschaftlichen Literatur zum Thema „New medicines“

Autor: Grafiati
Veröffentlicht am 4. Juni 2021
Zuletzt aktualisiert am 27. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "New medicines" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "New medicines"

1

Parry, Parvaiz Ahmad, Aadil Hussain Tantray, and Aadil Mustafa Shabir Ahmad Ganie Mr Rajan Kothari. "Nutraceuticals: New Concept of Medicines." International Journal of Trend in Scientific Research and Development Volume-2, Issue-4 (2018): 153–58. http://dx.doi.org/10.31142/ijtsrd12970.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Godlee, F. "Good medicine rather than new medicines." BMJ 344, jun27 1 (2012): e4417-e4417. http://dx.doi.org/10.1136/bmj.e4417.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

S. Masmare, Suchita, and Vaishnavi V. Chitmuiwar. "New Advance Innovative Packaging of Medicines." International Journal of Science and Research (IJSR) 12, no. 12 (2023): 1350–52. http://dx.doi.org/10.21275/sr231214161633.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Mufadhol, Mufadhol, Mustafid Mustafid, Jie Ferry, and Noor Hidayah Yuni. "The new model for medicine distribution by combining of supply chain and expert system using rule-based reasoning method." International Journal of Artificial Intelligence (IJ-AI) 12, no. 1 (2023): 295–304. https://doi.org/10.11591/ijai.v12.i1.pp295-304.

Der volle Inhalt der Quelle
Annotation:
The medicine distribution supply chain is important, especially during the coronavirus disease 2019 (COVID-19) pandemic, because delays in medicine distribution can increase the risk for patients. So far, the distribution of medicines has been carried out exclusively and even some medicines are distributed on a limited basis because they require strict supervision from the Medicine Supervisory Agency in each department. However, the distribution of this medicine has a weakness if at one public health center there is a shortage of certain types of medicines, it cannot ask directly to other publ
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Hewson, Campbell, Chong Chi Shen, Clare Strachan, and Pauline Norris. "Personal medicines storage in New Zealand." Journal of Primary Health Care 5, no. 2 (2013): 146. http://dx.doi.org/10.1071/hc13146.

Der volle Inhalt der Quelle
Annotation:
INTRODUCTION: Poor storage of medicines can reduce their efficacy, yet little is known about how people store medicines in their homes and elsewhere, why these locations are chosen, and whether the conditions are suitable for medicines storage. AIM: To investigate where medicines are commonly stored in New Zealand households, why, and the typical conditions – temperature and relative humidity – in those places of storage. METHODS: Data from a large qualitative study on the meanings of medicines were analysed to explore where people store medicines in their households, and why. A data logger wa
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Fox, Andrew. "Biosimilar Medicines—New Challenges for a New Class of Medicine." Journal of Biopharmaceutical Statistics 20, no. 1 (2009): 3–9. http://dx.doi.org/10.1080/10543400903549892.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Nind, Fred, and Pam Mosedale. "New medicines guide." BSAVA Companion 2009, no. 3 (2009): 20–21. http://dx.doi.org/10.22233/20412495.0309.20.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Mills, Ann. "Discovering new medicines." Trends in Pharmacological Sciences 16, no. 3 (1995): 116. http://dx.doi.org/10.1016/s0165-6147(00)88994-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Dean, S. "New medicines regulations." Veterinary Record 157, no. 19 (2005): 599. http://dx.doi.org/10.1136/vr.157.19.599.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

DeFranco, Joanna F., and Jeffrey Voas. "Computing New Medicines." Computer 56, no. 2 (2023): 12–13. http://dx.doi.org/10.1109/mc.2022.3191933.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Dissertationen zum Thema "New medicines"

1

McCoy, Jan. "New Medicines From Desert Plants?" College of Agriculture, University of Arizona (Tucson, AZ), 1990. http://hdl.handle.net/10150/295640.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Hostetler, Dana M. "New methods for the examination of poor quality medicines." Thesis, Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/43699.

Der volle Inhalt der Quelle
Annotation:
The production and distribution of counterfeit drugs is a critical health problem that plagues nations worldwide. The presence of counterfeit antimalarials has become especially worrying, as these drugs are most often needed by those living in nations whose resources to verify the medicine supply are lacking. Rapid analysis methods used for screening large quantities of poor quality antimalarials are critical in the battle to protect those in less developed regions of the world. Simple, cost effective analysis methods that can be used in the field must be developed so those whose government
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Villers, Trevor. "A thematic analysis of recent PHARMAC new medicines' subsidy decisions." Click here to access this resource online, 2008. http://hdl.handle.net/10292/386.

Der volle Inhalt der Quelle
Annotation:
PHARMAC, the Pharmaceutical Management Agency, manages the Pharmaceutical Schedule on behalf of the Government. The Agency is tasked with securing the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided (§ 47 NZPHD Act, 2000). The Agency reports that it continues to improve New Zealanders’ access to funded medicines. In determining which pharmaceuticals to fund, PHARMAC’s Operating Policies and Procedures (OPPs) state that nine criteria guide its decision- making. The OPPs further state that PHARMAC can apply whatever
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

譚郭雅欣 and Gloria Tam. "Non-small cell lung cancer clinical trials on new medicines." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41711956.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Tam, Gloria. "Non-small cell lung cancer clinical trials on new medicines." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41711956.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Wärn, Caroline. "Deviating time-to-onset in predictive models : detecting new adverse effects from medicines." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-257100.

Der volle Inhalt der Quelle
Annotation:
Identifying previously unknown adverse drug reactions becomes more important as the number of drugs and the extent of their use increases. The aim of this Master’s thesis project was to evaluate the performance of a novel approach for highlighting potential adverse drug reactions, also known as signal detection. The approach was based on deviating time-to-onset patterns and was implemented as a two-sample Kolmogorov-Smirnov test for non-vaccine data in the safety report database, VigiBase. The method was outperformed by both disproportionality analysis and the multivariate predictive model vig
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Drever, Benjamin David. "Genes, metals and herbal medicines : new insights into causes and treatments for Alzheimer's disease." Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources. Restricted access until July 1, 2104, 2009. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=26524.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Diego, del Río Laura 1977. "Independent drug information for medicines management." Doctoral thesis, Universitat Pompeu Fabra, 2013. http://hdl.handle.net/10803/129850.

Der volle Inhalt der Quelle
Annotation:
On the 50th anniversary of the creation of the first medicines information center, the core of this PhD Thesis offers an insider perspective and provides several examples of independent drug information, with a focus on new drugs. On the one hand, it provides an overview of the origins and challenges current medicines information centers within public healthcare organizations are experiencing. Several strategic lines aiming for information centers continue to meet drug information needs in the actual healthcare and economic context are presented. Additionally, various examples of independent d
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Linley, Warren G. "Reimbursement decisions for new medicines: exploration of the preferences of decision-makers and the public." Thesis, Bangor University, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.610915.

Der volle Inhalt der Quelle
Annotation:
Aims: This thesis explores the preferences of different stakeholders, particularly nationallevel decision-makers and the public, to determine the relevance of current and proposed criteria and processes for medicines reimbursement in the UK National Health Service. Methods and Results: Based on a systematic literature review of health-related conjoint ! analyses (Chapter 2), process-related aspects of health care are demonstrated to be I ,important to stakeholders, albeit less so than health outcomes. Using revealed preference Imethods (Chapter 3) and a stated preference discrete choice experi
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Allen, Nicola. "Development and application of classification methodologies for comparing reimbursement decision-making processes for new medicines." Thesis, Cardiff University, 2015. http://orca.cf.ac.uk/75508/.

Der volle Inhalt der Quelle
Annotation:
Health Technology Assessment (HTA) considers the therapeutic effectiveness of a health technology and may also evaluate cost-effectiveness. The aim of this study was to evaluate HTA agencies, their relationship to regulatory authorities and other decision-makers and to identify common appraisal practices with respect to the economic and therapeutic evaluation of new medicines. The national reimbursement pathways for 33 European jurisdictions were evaluated to identify two taxonomic sets that categorise HTA agencies by evaluating the relationship between the HTA, regulatory and decision-making
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Bücher zum Thema "New medicines"

1

Extein, Irl. New medicines of the mind. Berkeley Books, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Association, British Medical, ed. The new guide to medicines & drugs. 4th ed. Dorling Kindersley, 1998.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Riley, David S., ed. Materia Medica of New and Old Homeopathic Medicines. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-65920-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Riley, David S. Materia Medica of New and Old Homeopathic Medicines. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-25292-1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Riley, David S. Materia Medica of New and Old Homeopathic Medicines. Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-54192-0.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

service), SpringerLink (Online, ed. Materia Medica of New and Old Homeopathic Medicines. Springer-Verlag GmbH Berlin Heidelberg, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Teeling-Smith, George. The impact of new medicines on health care costs. Office of Health Economics, 1989.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Kaaiakamanu, D. M. Native Hawaiian medicines: A new revised and enlarged translation. First People's Productions, 1994.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

1939-, Henry John, and British Medical Association, eds. The British Medical Association new guide to medicines & drugs. 3rd ed. Colour Library Books, 1995.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

D, Stonier P., ed. Discovering new medicines: Careers in pharmaceutical research and development. Wiley, 1994.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen

Buchteile zum Thema "New medicines"

1

Cook, Harold. "Progress in Medicine and Medicines." In New Philosophical Perspectives on Scientific Progress. Routledge, 2022. http://dx.doi.org/10.4324/9781003165859-16.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Ribeill, Yves J. "Discovery of New Medicines." In The Textbook of Pharmaceutical Medicine. Blackwell Publishing Ltd., 2013. http://dx.doi.org/10.1002/9781118532331.ch1.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Aydeniz Acar, Gul Ebru. "Herbal Medicine Used During Pregnancy." In Complementary Medicine with New Approaches. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359418.14.

Der volle Inhalt der Quelle
Annotation:
The World Health Organization (WHO) defines herbal medicines as materials and preparations derived from plants and states that they must have therapeutic activity. Over the last two decades, the use of herbal medicine during pregnancy has increased significantly, especially among women. However, the safety of herbal medicines varies depending on the pregnancy period and caution should be exercised, especially in the first trimester. Although thought to be harmless because they are natural, these medications can trigger uterine contractions, cause hormonal imbalances, and harm the fetus. Herbal
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Inui, Akio. "Erratum to: Herbal Medicines: New Horizons." In Herbal Medicines. Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-4002-8_16.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Remya, V., Maggie Jo Alex, and Alex Thomas. "Quality Control of Ayurvedic Medicines." In Ayurveda in the New Millennium. CRC Press, 2020. http://dx.doi.org/10.1201/9780429298936-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Keller, Thomas H., Yen Liang Chen, John E. Knox, et al. "Finding New Medicines for Flaviviral Targets." In Novartis Foundation Symposia. John Wiley & Sons, Ltd, 2008. http://dx.doi.org/10.1002/0470058005.ch8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Remya, V., Alex Thomas, and D. Induchoodan. "Manufacture of Ayurvedic Medicines – Regulatory Aspects." In Ayurveda in the New Millennium. CRC Press, 2020. http://dx.doi.org/10.1201/9780429298936-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Gopinath, Nishanth. "Industrial Manufacture of Traditional Ayurvedic Medicines." In Ayurveda in the New Millennium. CRC Press, 2020. http://dx.doi.org/10.1201/9780429298936-3.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Stinson, John C. "The development of new medicines: an overview." In Biopharmaceuticals, an Industrial Perspective. Springer Netherlands, 1999. http://dx.doi.org/10.1007/978-94-017-0926-2_11.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Iskander, Dina. "TRIPS and Access to Medicines in Egypt." In The New Political Economy of Pharmaceuticals. Palgrave Macmillan UK, 2013. http://dx.doi.org/10.1057/9781137315854_5.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "New medicines"

1

Pisirgen, Ali, and Ourania Areta Hiziroglu. "Applications of Digital Twin in Precision Medicine: A Systematic Review." In 2025 International Conference on New Trends in Computing Sciences (ICTCS). IEEE, 2025. https://doi.org/10.1109/ictcs65341.2025.10989480.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Kelam, Nela, Branka Bernard, Janne Sørensen, and Sandra Kostić. "IMPLEMENTING DESIGNCARE: ENHANCING COMMUNICATION AND DIVERSITY COMPETENCE IN PARTICIPATORY MEDICINE EDUCATION." In 17th International Conference on Education and New Learning Technologies. IATED, 2025. https://doi.org/10.21125/edulearn.2025.1193.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

D'Alessio, Anna, and Carola Cirillo. "NARRATIVE MEDICINE: A BRIDGE BETWEEN SCIENCE AND HUMANITY IN HEALTH PRACTICE." In 17th International Conference on Education and New Learning Technologies. IATED, 2025. https://doi.org/10.21125/edulearn.2025.2404.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Camañes-Gonzalvo, Sara, María Dolores Casaña-Ruiz, Rocío Marco-Pitarch, et al. "INTEGRATING DENTAL SLEEP MEDICINE INTO POSTGRADUATE DENTAL EDUCATION: A SURVEY-BASED STUDY." In 17th International Conference on Education and New Learning Technologies. IATED, 2025. https://doi.org/10.21125/edulearn.2025.2194.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Graham, Myfanwy, Elianne Renaud, Catherine Lucas, Jennifer Schneider, and Jennifer Martin. "Medicinal cannabis prescribing guidance documents: An evidence-based, best-practice framework based on the New South Wales experience." In 2022 Annual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.02.000.51.

Der volle Inhalt der Quelle
Annotation:
Introduction: In 2018, the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), a National Health and Medical Research Council (NHMRC) Centre of Research Excellence was funded to develop a suite of state-wide medicinal cannabis prescribing guidance documents. At this time, regulatory changes in Australia were enabling broader access to medicinal cannabis in a medical model. The initiative funded through the New South Wales (NSW) Government’s Clinical Cannabis Medicines Program enabled the development of practical resources to support NSW medical practitioners in prescribi
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Huffman, MA. "The evolution of animal self-medication and lessons for the development of medicine and new medicines." In 67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) in cooperation with the French Society of Pharmacognosy AFERP. © Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-3399675.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Denisova, E. A., G. M. Goryainova, and L. V. Arsenyeva. "Quantitative analysis of veterinary medicines in animal products by immunominomicchip analysis." In БИОТЕХНОЛОГИЯ: НАУЧНЫЕ ИССЛЕДОВАНИЯ И СВЯЗЬ С ПРОИЗВОДСТВОМ. Всероссийский научно-исследовательский и технологический институт биологической промышленности, 2024. https://doi.org/10.47804/978-5-89904-038-2-2024-284-288.

Der volle Inhalt der Quelle
Annotation:
The detection of residual amounts of medicinal substances in food products of animal origin remains an urgent issue, which requires the constant introduction and adaptation of new methods of indication. Our studies have shown the effectiveness of determining the residual amounts of medicines using immunomicrochip technology test systems.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Williams, Gareth. "Contribution of the Keynote Speaker - Novel Nanotechnologies for New Medicines." In SLIIT INTERNATIONAL CONFERENCE ON ADVANCEMENTS IN SCIENCES AND HUMANITIES. Faculty of Humanities & Sciences, SLIIT, 2024. https://doi.org/10.54389/webi4830.

Der volle Inhalt der Quelle
Annotation:
In order to be effective, a drug must be delivered to the right part of the body, at the correct time, and in an appropriate amount. If any one of these three criteria is not met, then a medicine will be ineffective or even dangerous. To develop potent medicines, pharmaceutical scientists need to find ways to enhance the intrinsic properties of drug molecules, for instance by increasing their solubility in water. There are a number of technologies which have been adopted to achieve these goals. One emerging approach which is attracting significant interest is electrospinning, which applies an
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Corell Domenech, María Vicenta, and Olga Mayoral García-Berlanga. "WHAT DO TEACHER TRAINING STUDENTS THINK ABOUT COMPLEMENTARY AND ALTERNATIVE MEDICINES?" In 10th International Conference on Education and New Learning Technologies. IATED, 2018. http://dx.doi.org/10.21125/edulearn.2018.2323.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Jenoui, Kaoutar, and Abdellah Abouabdellah. "Determining a new multi-level criteria evaluation strategy for medicines suppliers." In 2018 4th International Conference on Logistics Operations Management (GOL). IEEE, 2018. http://dx.doi.org/10.1109/gol.2018.8378076.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "New medicines"

1

Jaspars, Marcel. Diving into the abyss for new medicines. Monash University, 2022. http://dx.doi.org/10.54377/4ebb-235d.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Johnson, Paul. Like new medicines, new policies should first be put to the test. The IFS, 2011. http://dx.doi.org/10.1920/co.ifs.2024.0931.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Adam Leotta, Adam Leotta. From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation. Experiment, 2014. http://dx.doi.org/10.18258/3642.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Adams, Alyce, Andrea Altschuler, Elizabeth Bayliss,, et al. Automated Tracking of Symptoms and Treatment Side Effects to Help Patients Starting New Medicines for Diabetes-Related Nerve Pain. Patient-Centered Outcomes Research Institute (PCORI), 2019. http://dx.doi.org/10.25302/5.2019/ce.13047250.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Collington, Rosie, and William Lazonick. Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access. Institute for New Economic Thinking Working Paper Series, 2022. http://dx.doi.org/10.36687/inetwp176.

Der volle Inhalt der Quelle
Annotation:
The United States represents the world’s largest market for pharmaceutical drugs. It is also the only advanced economy in the world that does not regulate drug prices. There is no upper threshold for the prices of medicines in the United States. List prices are instead set by manufacturers in negotiation with supply-chain intermediaries, though some federal programs have degrees of discretion in price determinations. In practice, this deregulated system means that drug prices in the United States are generally far higher than in other advanced economies, adversely affecting patient accessibili
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Milsom, Penelope, and David McCoy. Corporate accountability in global health governance? A case study of the Access to Medicine Index (Addendum). United Nations University - International Institute for Global Health, 2025. https://doi.org/10.37941/rr/2025/2.

Der volle Inhalt der Quelle
Annotation:
In October 2024, UNU-IIGH published an extensive analysis of the 2022 Access to Medicine Index (AtMI) and the underlying theory of how the Index promotes increasingly socially responsible corporate policies and practices over time. The analysis identified several limitations of 2022 AtMI. These included: data quality concerns about incomplete and reliable data; a lack of clarity about how data are translated into company scores for each indicator; the low standards against which companies are assessed; and the narrow scope of corporate conduct covered by the Index. While noting some improvemen
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Musa, Padde, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Knowledge Sharing in Organisations: Finding a Best-fit Model for a Regulatory Authority in East Africa. Purdue University, 2021. http://dx.doi.org/10.5703/1288284317432.

Der volle Inhalt der Quelle
Annotation:
Knowledge is an essential organisational asset that contributes to organisational effectiveness when carefully managed. Knowledge sharing (KS) is a vital component of knowledge management that allows individuals to engage in new knowledge creation. Until it’s shared, knowledge is considered useless since it resides within the human brain. Public organisations specifically, are more involved in providing and developing knowledge and hence can be classified as knowledge-intensive organisations. Scholarly research conducted on KS has proposed a number of models to help understand the KS process b
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Burchiel, Scott W. New Mexico Center for Isotopes in Medicine. Office of Scientific and Technical Information (OSTI), 2012. http://dx.doi.org/10.2172/1057277.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Aguillaume, C. J. Is Refugee and War Medicine Becoming a New Specialty? Defense Technical Information Center, 1993. http://dx.doi.org/10.21236/ada275101.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Costanzo, Dino G. 2009 New England American College of Sports Medicine Conference. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada604083.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Die Auswahlen zum Thema "New medicines" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel Dissertationen Bücher
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie